AKIPRESS.COM - Diaverum, one of the world’s leading renal care providers, announced the acquisition of Nefros Asia in Kazakhstan with nine kidney centres across the country.

The centres will shortly begin the integration into the global renal care network of Diaverum across Europe, Middle East, Latin America and Australia.

With the Nefros acquisition, Diaverum is taking a first footstep into the Asian market. Local patients, staff and payers will benefit from Diaverum’s high standards of clinical excellence, world-class training and education programmes, and a patient-first approach.

The centres acquired by Diaverum in Kazakhstan are located in Almaty, Kaskelen, Karaganda, Kokshetau, Kostanay, Aktobe, Aksai and Uralsk.

In Kazakhstan, renal disease presents a large challenge with strong growth in the number of patients needing renal replacement therapy. In 2013, approximately 2,100 dialysis patients were in need of renal replacement therapy. By the end of 2014 this figure is estimated to have risen to approximately 3,800 patients.

“Kazakhstan is currently increasing the number of facilities for dialysis treatments across the country, but the quality is still in need of improvement,” said Sardar Sadykov, Managing Director of Diaverum Kazakhstan.

Diaverum is a Swedish-owned firm which specializes in providing kidney dialysis services.